IP Library Granted Patent US 8,551,008
Granted Patent B2
US 8,551,008 · App. 11/871,901 · Granted Oct 8, 2013

Method and apparatus for determining vascular health conditions

Inventors: Morteza Naghavi (Houston, TX); Nachiket Kharalkar (Austin, TX); Timothy J. O'Brien (Anoka, MN)
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,551,008
App. No.
11/871,901
Granted
Oct 8, 2013
Kind
B2
Abstract

The present invention relates to assessing and measuring vascular and endothelial function. A vasostimulant is provided to a patient to stimulate hemodynamic activity in a selected extremity and vascular function is assessed by monitoring a change in a blood flow, skin temperature and/or blood oxygen content at the selected extremity and assessing the patient's vascular function based upon the monitoring.

Claims (33)

1. A method for assessing arterial reactivity in a patient, comprising:

a) providing a vasodilating stimulant to a patient by creating an arterial occlusion at a body part of said patient using one or more pressure cuffs thereby stimulating arterial reactivity in a first region of said body part of said patient;

b) simultaneously monitoring a patient's skin surface temperature at the first region and at a second control region before the arterial occlusion, during the arterial occlusion, and after the arterial occlusion is removed and until an equilibrium temperature is achieved using a temperature measurement device that does not substantially apply any one of thermal energy, positive pressure and negative pressure to the skin surface; wherein said second control region and said first region are located at contralateral body parts; and

c) identifying a baseline temperature at the first region before the arterial occlusion;

d) identifying a peak temperature at the first region after the arterial occlusion; and

e) assessing arterial reactivity in said patient based on temperature changes at the second control region and a rebound temperature change related to said baseline temperature and said peak temperature at the first region.

2. The method of claim 1 for assessing arterial reactivity further comprising:

a) creating the arterial occlusion for a predetermined period of time; and

b) ceasing the occlusion after the predetermined period of time.

3. The method of claim 1 , wherein providing a vasodilating stimulant comprises occluding blood flow to at least one of: (i) a leg, (ii) ankle, (iii) toe, (iv) arm, (v) wrist, and (vi) a finger.

4. The method of claim 1 , wherein said monitoring occurs from a time prior to the beginning of said compression until a time after the hemodynamic activity has reached equilibrium.

5. The method of claim 1 , wherein the monitoring comprises measuring changes in temperature at one of the patient's fingertips.

6. The method of claim 5 , further comprising plotting the measured changes in temperature as a function of time.

7. A method for assessing arterial reactivity in a patient comprising:

a) measuring a first equilibrium skin temperature at a first region of a body part of said patient using a temperature measurement device that does not substantially apply any one of thermal energy, positive pressure, and negative pressure to said first region of the patient;

b) compressing arteries of said body part of the patient using a pressure cuff such that arterial blood flow in said first region of said body part is occluded;

c) simultaneously measuring skin temperature at the first region and at a second control region of said body part during cuff compression, after release of the cuff and until a second temperature equilibrium is achieved; wherein the second control region does not undergo arterial blood flow occlusion said cuff compression;

d) identifying a peak temperature at the first region after release of the cuff; and

e) assessing the patient's arterial reactivity based upon temperature changes at the second control region and a rebound temperature change related to said first equilibrium temperature and said peak temperature at the first region.

8. The method of claim 7 , wherein said first region is a digit.

9. The method of claim 8 , wherein the digit is a finger and the temperature is measured on a fingertip.

10. The method of claim 7 , comprising occluding blood flow in at least one extremity for a predetermined period of time and ceasing compression after the predetermined period of time, wherein said first region consists of one or more of: a leg, ankle, toe, arm, wrist, and a finger.

11. The method of claim 7 , wherein the measuring is conducted from a time prior to the occluding blood flow with a compressing cuff until a time after a equilibrium temperature is reached after ceasing compression.

12. The method of claim 7 , further comprising plotting the measured temperature as a function of time.

13. A method for determining a arterial reactivity status in a patient comprising:

a) initiating monitoring of skin surface temperature at a selected point of a selected region the patient until a first equilibrium temperature is reached using a temperature sensor that does not substantially change the skin temperature;

b) while continuing the monitoring, occluding arterial blood flow to the selected point for a predetermined period of time by providing a vasodilating stimulant using a pressure cuff and ceasing the occlusion after the predetermined period of time;

c) simultaneously with said monitoring and said occluding, monitoring skin surface temperature at a control point that does not undergo arterial flow occlusion until the skin surface temperature of the selected point has reached a second equilibrium after ceasing the occlusion;

d) identifying a peak temperature at the selected point after release of the cuff; and

e) assessing the patient's arterial reactivity based upon temperature changes at the control point and a rebound temperature change related to said first equilibrium temperature and said peak temperature at the selected point.

14. The method of claim 13 , further comprising plotting the monitored temperature as a function of time.

15. The method of claim 13 , wherein the selected region is a finger and the temperature is measured at a point on the skin surface of a fingertip.

16. The method of claim 13 , wherein the blood flow is occluded at one or more regions selected from the group consisting of: a leg, ankle, toe, arm, wrist, and a finger.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 28, 2007
From: NAGHAVI, MORTEZA; O'BRIEN, TIMOTHY J
To: ENDOTHELIX
Reel/Frame 020302/0957 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 28, 2007
From: KHARALKAR, NACKIKET M
To: BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
Reel/Frame 020302/0967 →
Continuity (10)
Continuation 11563676 · Nov 27, 2006
Continuation In Part PCTUS2005018437 · May 25, 2005
Continuation In Part 11871901
Continuation In Part 10525255
Provisional Application 60585773 · Jul 6, 2004
Provisional Application 60574255 · May 26, 2004
Provisional Application 60626006 · Nov 8, 2004
Provisional Application 60628173 · Nov 15, 2004
Provisional Application 60405352 · Aug 23, 2002
Related Publication 20080255471A1 · Oct 16, 2008